Osimertinib vs Pembrolizumab

## Osimertinib vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Osimertinib** and **Pembrolizumab**.

## Mechanism of Action

**Osimertinib**: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Osimertinib — 48 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Osimertinib — C28H33N7O2; Pembrolizumab — N/A.

**Molecular Weight**: Osimertinib — 499.6050 g/mol; Pembrolizumab — N/A.

**Type**: Osimertinib — Small molecule; Pembrolizumab — Antibody.